Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123363303 | 12336330 | 3 | F | 201412 | 20160719 | 20160505 | 20160725 | EXP | GB-DRREDDYS-GER/UKI/16/0079402 | DR REDDYS | 61.00 | YR | M | Y | 105.00000 | KG | 20160725 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123363303 | 12336330 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Y | Y | UNKNOWN | 76692 | |||||||||
| 123363303 | 12336330 | 2 | SS | CALCIUM CHANNEL BLOCKERS | UNSPECIFIED INGREDIENT | 1 | Y | U | 0 | ||||||||||
| 123363303 | 12336330 | 3 | SS | INDAPAMIDE. | INDAPAMIDE | 1 | 80 | MG | Y | U | 0 | 2.5 | MG | TABLET | QD | ||||
| 123363303 | 12336330 | 4 | SS | NATRILIX SR | INDAPAMIDE | 1 | U | 0 | 1.5 | MG | COATED TABLET | ||||||||
| 123363303 | 12336330 | 5 | C | DOXAZOSIN MESILATE | DOXAZOSIN MESYLATE | 1 | 0 | ||||||||||||
| 123363303 | 12336330 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | 20 | MG | BID | |||||||||
| 123363303 | 12336330 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG IN MORNING, 40 MG IN EVENING | 0 | |||||||||||
| 123363303 | 12336330 | 8 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
| 123363303 | 12336330 | 9 | C | REGURIN | 2 | 0 | |||||||||||||
| 123363303 | 12336330 | 10 | C | VALSARTAN. | VALSARTAN | 1 | 80 MG, QD | 0 | 80 | MG | QD | ||||||||
| 123363303 | 12336330 | 11 | C | CHLORTHALIDONE. | CHLORTHALIDONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123363303 | 12336330 | 1 | Hypertension |
| 123363303 | 12336330 | 2 | Hypertension |
| 123363303 | 12336330 | 3 | Hypertension |
| 123363303 | 12336330 | 4 | Hypertension |
| 123363303 | 12336330 | 5 | Product used for unknown indication |
| 123363303 | 12336330 | 6 | Product used for unknown indication |
| 123363303 | 12336330 | 8 | Product used for unknown indication |
| 123363303 | 12336330 | 9 | Product used for unknown indication |
| 123363303 | 12336330 | 10 | Product used for unknown indication |
| 123363303 | 12336330 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123363303 | 12336330 | LT |
| 123363303 | 12336330 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123363303 | 12336330 | Cerebrovascular accident | |
| 123363303 | 12336330 | Drug ineffective | |
| 123363303 | 12336330 | Glomerular filtration rate decreased | |
| 123363303 | 12336330 | Hypervolaemia | |
| 123363303 | 12336330 | Impaired quality of life | |
| 123363303 | 12336330 | Oedema peripheral | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123363303 | 12336330 | 1 | 2015 | 2015 | 0 | |
| 123363303 | 12336330 | 2 | 2015 | 2015 | 0 | |
| 123363303 | 12336330 | 3 | 20141030 | 2015 | 0 | |
| 123363303 | 12336330 | 4 | 2015 | 0 | ||
| 123363303 | 12336330 | 7 | 20160215 | 20160309 | 0 |